Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-Finding Study to Assess the Safety, Tolerability, and Immunogenicity of Inactivated Streptococcus Pneumoniae Whole Cell Vaccine Formulated With Alum (PATH-wSP) in Healthy Kenyan Young Adults and PCV-Primed Toddlers

NCT02097472 is registered in ClinicalTrials.gov with PATH as lead sponsor.

NCT NCT02097472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02097472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-Finding Study to Assess the Safety, Tolerability, and Immunogenicity of Inactivated Streptococcus Pneumoniae Whole Cell Vaccine Formulated With Alum (PATH-wSP) in Healthy Kenyan Young Adults and PCV-Primed Toddlers
Lead sponsor
PATH
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2014
Completion date
December 31, 2015
Enrollment
304 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia, pneumococcal